Veradermics, Inc (MANE) stock
MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$125.64−2.41 (-1.88%)
Close on Nov 17, 2026Market cap $5.25BP/E –Yield –
Veradermics total assets
Total assets on the balance sheet at the end of each period.
Veradermics's total assets was $825.74M at Jun 30, 2026. For fiscal 2025 it was $152.62M, up 174.8% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.62M | +174.8% |
| FY2024 | Dec 31, 2024 | $55.54M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $825.74M | – |
| Q1 FY2026 | Mar 31, 2026 | $397.36M | – |
| Q4 FY2025 | Dec 31, 2025 | $152.62M | – |
| Q4 FY2024 | Dec 31, 2024 | $55.54M | – |
See a number that looks wrong?